PRL and Anxiety: Previous work investigating the functional consequences of prolactin‐induced SVZ mitogenesis showed that blocking prolactin secretion using the dopamine D2 agonist bromocriptine during early pregnancy caused consequential deficits in maternal care and increased anxiety‐like behavior post‐partum.10, 11